Correlation Between Avanos Medical and Quaker Chemical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avanos Medical and Quaker Chemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avanos Medical and Quaker Chemical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avanos Medical and Quaker Chemical, you can compare the effects of market volatilities on Avanos Medical and Quaker Chemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avanos Medical with a short position of Quaker Chemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avanos Medical and Quaker Chemical.

Diversification Opportunities for Avanos Medical and Quaker Chemical

AvanosQuakerDiversified AwayAvanosQuakerDiversified Away100%
-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Avanos and Quaker is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Avanos Medical and Quaker Chemical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quaker Chemical and Avanos Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avanos Medical are associated (or correlated) with Quaker Chemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quaker Chemical has no effect on the direction of Avanos Medical i.e., Avanos Medical and Quaker Chemical go up and down completely randomly.

Pair Corralation between Avanos Medical and Quaker Chemical

Assuming the 90 days trading horizon Avanos Medical is expected to generate 1.64 times more return on investment than Quaker Chemical. However, Avanos Medical is 1.64 times more volatile than Quaker Chemical. It trades about -0.08 of its potential returns per unit of risk. Quaker Chemical is currently generating about -0.25 per unit of risk. If you would invest  1,650  in Avanos Medical on September 21, 2024 and sell it today you would lose (90.00) from holding Avanos Medical or give up 5.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Avanos Medical  vs.  Quaker Chemical

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -25-20-15-10-50510
JavaScript chart by amCharts 3.21.158HH QUC
       Timeline  
Avanos Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avanos Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec161718192021
Quaker Chemical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Quaker Chemical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Quaker Chemical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
JavaScript chart by amCharts 3.21.15OctNovDecNovDec140145150155160165

Avanos Medical and Quaker Chemical Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-5.35-4.0-2.66-1.32-0.02241.112.263.414.565.71 0.040.050.060.07
JavaScript chart by amCharts 3.21.158HH QUC
       Returns  

Pair Trading with Avanos Medical and Quaker Chemical

The main advantage of trading using opposite Avanos Medical and Quaker Chemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avanos Medical position performs unexpectedly, Quaker Chemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quaker Chemical will offset losses from the drop in Quaker Chemical's long position.
The idea behind Avanos Medical and Quaker Chemical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets